Advanced Technology at UC CHRISTUS Expands Access to
Minimally Invasive Surgery for More Patients
DUBLIN, July 20, 2021 /PRNewswire/ -- Medtronic plc
(NYSE:MDT), the global leader in medical technology, today
announced the integration of the Hugo™ robotic-assisted
surgery (RAS) system at Hospital Clinico de la Red de Salud UC
CHRISTUS in Santiago, Chile, to
support the teaching institution's new robotic surgery program. UC
CHRISTUS is the latest institution to join Medtronic's Partners in
Possibility Program, a group of pioneering hospitals that will
be among the first in the world to use the Hugo RAS system in
support of the Hugo system patient registry.
"Our surgical robotics vision — to expand access to quality care
to more people in more places — is coming to life at UC CHRISTUS,"
said Carla Peron, M.D., chief
medical officer of the Surgical Robotics business, which is part of
the Medical Surgical Portfolio at Medtronic. "It's incredibly
exciting to see our teams working together to bring surgical
robotics where it couldn't exist before, all for the benefit of
patients."
In Latin America, approximately
75% of surgeries are conducted as open procedures.1 With
minimally invasive surgery, those patients could experience
fewer complications, shorter hospital stays, faster return to
normal activities, and smaller scars.2–4,†,‡
Robotic surgery is a form of minimally invasive surgery that
offers surgeons improved visualization, greater dexterity, and
ergonomic advantages, yet robots are used in less than 3% of
surgeries globally.1 The Hugo RAS system — Medtronic's
solution to historic cost and utilization barriers that have kept
surgical robotics out of reach for many hospitals — is a modular,
multi-quadrant platform designed for a broad range of soft-tissue
procedures.
The Hugo RAS system combines the precision of wristed
instruments with the flexibility of independent robotic arm carts
and best-in-class 3D visualization technology on an open console.
Touch Surgery™ Enterprise, a cloud-based surgical video capture
option powered by artificial intelligence, allows surgeons to
seamlessly record, analyze, and share Hugo system case footage.
"I am honored to have performed the inaugural robotic-assisted
surgery procedure for UC CHRISTUS and to be leading this program,
the first of its kind for our institution," said Ignacio San Francisco, M.D., urological surgeon
and specialist in minimally invasive uro-oncology surgery. "With
Hugo RAS system, we are entering a new era of robotic-assisted
surgery, improving how we deliver high quality healthcare to our
patients."
In support of its commitment to expand access to quality care,
Medtronic has opened a new Surgical Robotics Experience Center in
Santiago. This is the company's
first in Latin America and 1 of 10
world-class facilities around the globe where clinicians can
experience and train on the Hugo RAS system. The Santiago Surgical
Robotics Experience Center operates in partnership with the Faculty
of Medicine of Pontificia Universidad Católica de Chile, which is affiliated with UC
CHRISTUS.
"We are confident that our new robotic surgery program is ready
for success and will provide our patients with leading-edge quality
healthcare, thanks to the novel capabilities of the Hugo RAS
system, the support we have received from our partners at
Medtronic, and our outstanding surgeons," said Alejandro Canavati, chief executive officer, Red
de Salud UC CHRISTUS. "As a teaching institution, we are proud to
serve as a premier destination for world-class surgical robotics
training for physicians across the region."
The Hugo RAS system is not cleared or approved in the U.S. or
Europe. Regulatory requirements of
individual countries and regions will determine availability and
approval or clearance timelines. Touch Surgery Enterprise is not
intended to direct surgery, or aid in diagnosis or treatment of a
disease or condition.
About Medtronic
Medtronic plc (www.medtronic.com),
headquartered in Dublin, Ireland,
is among the world's largest medical technology, services and
solutions companies – alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 90,000 people worldwide, serving physicians,
hospitals and patients in more than 150 countries. The company is
focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
†Compared to open surgery.
‡MIS may not be suitable for every patient; consult your doctor to
determine if MIS is an option for you.
1. Based on Medtronic report, FY20 market model: procedural volume
data.
2. Fitch K, Engel T, Bochner A. Cost differences between open and
minimally invasive surgery. Managed Care. 2015
Sep;24(9):40–48.
3. Tiwari MM, Reynoso JF, High R, Tsang AW, Oleynikov D. Safety,
efficacy, and cost effectiveness of common laparoscopic
procedures. Surg Endosc. 2011;25(4):1127–1135.
4. Roumm AR, Pizzi L, Goldfarb NI, Cohn H. Minimally invasive:
minimally reimbursed? An examination of six laparoscopic surgical
procedures. Surg Innovation.2005;12(3):261–287.
Contacts:
|
|
|
|
Gary
Jeanfaivre
|
Ryan
Weispfenning
|
Public
Relations
|
Investor
Relations
|
+1-203-833-2104
|
+1-763-505-4626
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medtronic-hugo-robotic-assisted-surgery-system-cornerstone-of-new-robotics-program-in-latin-america-301337517.html
SOURCE Medtronic plc